Koyfin Home > Directory > Health Care > Amicus Therapeutics > Other Liabilities

Amicus Therapeutics Other Liabilities Chart (FOLD)

Amicus Therapeutics annual/quarterly Other Liabilities from 2006 to 2018.
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Other Liabilities for the last 12 months ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Annual Other Liabilities for 2018 was $39m a -2.02% decrease of -1m from 2017
  • Amicus Therapeutics Annual Other Liabilities for 2017 was $40m a -929.03% decrease of -371m from 2016
  • Amicus Therapeutics Annual Other Liabilities for 2016 was $411m a -8.28% decrease of -34m from 2015
Other Balance Sheet Metrics:
  • Amicus Therapeutics Total Assets for the quarter ending September 09, 2018 was $839m a 25.23% increase of 212m year over year
  • Amicus Therapeutics Total Equity for the quarter ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
View Chart On Koyfin

Quarterly FOLD Other Liabilities Data

12/2018$39m
09/2018$43m
06/2018$42m
03/2018$41m
12/2017$40m
09/2017$41m
06/2017$412m
03/2017$416m
12/2016$411m
09/2016$430m

Annual FOLD Other Liabilities Data

2018$39m
2017$40m
2016$411m
2015$445m
2014$57m
2013$57m
2012$31m
2011$21m
2010$30m
2008$44m